LoadingLoadingLoadingThe quick read
Latest quote·Oct 9
Net selling: insiders sold $28.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $28.3M and bought $0 of JHX stock on the open market in the 90 days to Oct 16, 2026, according to SEC Form 4 filings. The largest was Singh, Jesse G (Director), who sold $26.3M. The latest filing was on Aug 27, 2026.
None. No member of Congress disclosed a JHX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 16, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (2)
Millennium
$305.0M
added
Qube Research
$107.6M
added
Sells/Trims (1)
Citadel
$58.8M
trimmed
Buys (1)
Rowland Suzanne B
$69K
bought
Sells (2)
Skelly Jonathan
$2.0M
sold
Singh Jesse G
$26.3M
sold
No tracked top-trader positions in JHX right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.32 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $0.36 / $0.32Alpha Vantage | +12.50% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 19, 2026 | $0.30 / $0.30Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 10, 2026 | $0.24 / $0.22Alpha Vantage | +9.09% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 17, 2025 | $0.26 / $0.25Alpha Vantage | +4.00% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 19, 2025 | $0.29 / $0.29Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Mar 31, 2025 | May 20, 2025 | $0.10 / $0.37Alpha Vantage | -72.74% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 18, 2025 | $0.33 / $0.35Alpha Vantage | -6.71% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | $0.19 / $0.34Alpha Vantage | -42.29% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 16, 2026
EPS expected
$0.31 to $0.42
Revenue expected
15 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Richly priced and running thin margins.
Valuation
Quality
Growth
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
